Target intelligence / Profile preview

Bacterial DNA primase (DnaG)

Target
DnaG
Molecular classification
Enzyme, RNA polymerase, Transferase
01

Overview

Bacterial DNA primase, primarily known as DnaG, is an essential enzyme within the bacterial replisome responsible for synthesizing short RNA primers (NIH, 2018; Wikipedia). These primers are critical for the initiation of DNA synthesis by DNA polymerase, particularly on the lagging strand where they initiate the formation of Okazaki fragments (NIH, 2015; Wikipedia). Because DNA polymerases cannot start DNA synthesis de novo, the activity of primase is indispensable for bacterial cell division and survival (ASM, 2017; Wikipedia). Structurally, bacterial primases are distinct from their eukaryotic counterparts, typically consisting of three domains: a zinc-binding domain for DNA recognition, an RNA polymerase domain for catalysis, and a helicase-binding domain for interaction with the DnaB helicase (NIH, 2018; ResearchGate). This structural divergence makes bacterial DNA primase an attractive target for the development of novel antibiotics, especially against drug-resistant pathogens like Mycobacterium tuberculosis (IJARBS, 2023; ASM, 2017). Inhibitors of this enzyme, such as certain small molecules and natural products, work by halting the replication fork, which ultimately leads to bacteriocidal effects (NIH, 2018; ResearchGate).

Other names
DnaGDnaG primasednaPDNA-dependent RNA polymerase
02

Mechanism of action

Inhibition of RNA primer synthesis, halting DNA replication.

03

Biological functions

DNA replicationRNA primer synthesisOkazaki fragment initiationCell proliferation
04

Disease associations

InfectionTuberculosis
05

Safety considerations

Selectivity over human primasePotential for antibiotic resistanceTherapeutic challenges due to slow catalytic turnover
06

Interacting drugs

Suramin

3 more in the full profile.

Beyond the preview

Go deeper on Bacterial DNA primase (DnaG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial DNA primase (DnaG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call